47 related articles for article (PubMed ID: 1690950)
21. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
Ornstein DL; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Hunt J; Rousseau SM; Stump DC
Cancer; 1991 Sep; 68(5):1061-7. PubMed ID: 1913476
[TBL] [Abstract][Full Text] [Related]
22. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Cancer; 1990 Feb; 65(3):481-5. PubMed ID: 2153429
[TBL] [Abstract][Full Text] [Related]
23. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Moritz TE; Rousseau SM; Stump DC
Cancer; 1991 Mar; 67(5):1377-83. PubMed ID: 1703919
[TBL] [Abstract][Full Text] [Related]
24. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.
Zacharski LR; Memoli VA; Ornstein DL; Rousseau SM; Kisiel W; Kudryk BJ
J Natl Cancer Inst; 1993 Aug; 85(15):1225-30. PubMed ID: 8331683
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Anticancer Res; 1990; 10(3):579-82. PubMed ID: 2114816
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Am J Clin Pathol; 1990 Apr; 93(4):516-21. PubMed ID: 1690950
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
Hoppe B
Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
[TBL] [Abstract][Full Text] [Related]
28. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
29. Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures.
Korte W
Clin Chem Lab Med; 2000 Aug; 38(8):679-92. PubMed ID: 11071061
[TBL] [Abstract][Full Text] [Related]
30. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
31. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
32. Coagulation and fibrinolysis in gastric cancer.
Repetto O; De Re V
Ann N Y Acad Sci; 2017 Sep; 1404(1):27-48. PubMed ID: 28833193
[TBL] [Abstract][Full Text] [Related]
33. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
34. Tumor growth and metastases in malignant disease. A review.
Kwaan HC
J Med; 1988; 19(3-4):179-91. PubMed ID: 3141546
[TBL] [Abstract][Full Text] [Related]
35. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
Bouma BN; Mosnier LO
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):375-81. PubMed ID: 15692247
[TBL] [Abstract][Full Text] [Related]
36. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
37. Inhibition of Fibrinolysis by Coagulation Factor XIII.
Rijken DC; Uitte de Willige S
Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
[TBL] [Abstract][Full Text] [Related]
38. What drives "fibrinolysis"?
Medcalf RL
Hamostaseologie; 2015; 35(4):303-10. PubMed ID: 25564072
[TBL] [Abstract][Full Text] [Related]
39. Pathways of coagulation/fibrinolysis activation in malignancy.
Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
[TBL] [Abstract][Full Text] [Related]
40. Blood coagulation and fibrinolysis: an overview.
Mosher DF
Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI5-11. PubMed ID: 2191814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
